Back to top

Verastem weakness appears overdone, says Mizuho

Mizuho reiterated an Outperform rating and $15 price target on Verastem (VSTM), noting the shares are falling intraday following the company’s Q3 r...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Verastem, Inc. (VSTM)